NCT06473506View on ClinicalTrials.gov

Group A Streptococcus Saliva Study

NAActive, not recruitingINTERVENTIONAL
Enrollment

200

Participants

Timeline

Start Date

June 10, 2024

Primary Completion Date

February 28, 2025

Study Completion Date

September 1, 2025

Conditions
Group A Streptococcal Infections
Interventions
DIAGNOSTIC_TEST

Saliva collection

Self-collected saliva sample with molecular testing performed. Results are compared to rapid antigen testing, bacterial throat culture and bacterial throat molecular testing

Trial Locations (2)

M5G1X8

Monica Caldeira-Kulbakas, Toronto

Unknown

The Hospital for Sick Children, Toronto

All Listed Sponsors
lead

The Hospital for Sick Children

OTHER

NCT06473506 - Group A Streptococcus Saliva Study | Biotech Hunter | Biotech Hunter